2008
DOI: 10.1038/onc.2008.176
|View full text |Cite
|
Sign up to set email alerts
|

Twist and p53 reciprocally regulate target genes via direct interaction

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
109
1
1

Year Published

2008
2008
2021
2021

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 116 publications
(115 citation statements)
references
References 32 publications
4
109
1
1
Order By: Relevance
“…[14][15][16] The protein concentrations were determined using a Protein Assay Kit (Bio-Rad, Hercules, CA, USA) based on Bradford's method. Whole-cell extracts (30 mg) were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to polyvinylidine difluoride microporous membranes (Micron Separations, Westborough, MA, USA) using a semidry blotter.…”
Section: Western Blottingmentioning
confidence: 99%
See 1 more Smart Citation
“…[14][15][16] The protein concentrations were determined using a Protein Assay Kit (Bio-Rad, Hercules, CA, USA) based on Bradford's method. Whole-cell extracts (30 mg) were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to polyvinylidine difluoride microporous membranes (Micron Separations, Westborough, MA, USA) using a semidry blotter.…”
Section: Western Blottingmentioning
confidence: 99%
“…[14][15][16] The following doublestranded RNA 25-basepair oligonucleotides were commercially generated (Invitrogen): 5 0 -AAGUGAG CGAAACUGUUUCCAAGGC-3 0 (sense) and 5 0 -GCCU UGGAAACAGUUUCGCUCACUU-3 0 (antisense) for GNMT siRNA #1; 5 0 -AUGUUGUGACGUCCUUGGU CAAGUC-3 0 (sense) and 5 0 -GACUUGACCAAGGAC GUCACAACAU-3 0 (antisense) for GNMT siRNA #2. RWPE-1, PC-3, and LNCaP cells were transfected with the indicated amounts of siRNA using Lipofectamine 2000 (Invitrogen) according to the manufacturer's protocol.…”
Section: Knockdown Analysis Using Sirnasmentioning
confidence: 99%
“…76 Several other mechanisms may also contribute to the p53-inhibitory activity of TWIST1, including inhibition of acetyltransferases that serve as transcriptional coactivators for p53, 77 modulation of the activity of a transactivator of the TP53 promoter, 78 prevention of p53 phosphorylation, 78 and direct suppression of the DNA-binding activity of p53. 79 Of note, the TWIST1 and TWIST2 proteins have also recently been shown to prevent oncogene-induced premature senescence with concomitant abrogation of p16 INK4a and p21 WAF1/CIP1 activation, and to induce, in cooperation with activated mitogenic oncoproteins, epithelial-mesenchymal transition, suggesting a role as general inhibitors of multiple oncogene-induced safeguard programs. 80 Inactivation of the p14 ARF -p53 Pathway by BMI1…”
Section: Transactivation Of Mdm2 Expression By Mycnmentioning
confidence: 99%
“…Twist1 prevents activation of p53 through multiple mechanisms, such as down-regulation of alternative reading frame protein (ARF), 15 and through direct interactions. 49 Further experiments will be necessary to determine what role p53 plays in RLFs following Twist1 depletion.…”
Section: Pulmonary Fibrosis and Twist1mentioning
confidence: 99%